Abstract
In the title compound, C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) Å. The chlorophenyl rings are twisted out of the plane of the pyrazole ring by 75.1 (1) and 39.5 (1)°. The crystal packing is controlled by weak intermolecular C—H⋯π interactions.
Highlights
In the title compound, C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) A
The crystal packing is controlled by weak intermolecular C—HÁ Á Á interactions
Cg3 and Cg5 are the centroids of the C14–C19 and C26–C31 rings, respectively
Summary
Key indicators: single-crystal X-ray study; T = 293 K; mean (C–C) = 0.003 A; R factor = 0.052; wR factor = 0.160; data-to-parameter ratio = 29.3. C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) A. The chlorophenyl rings are twisted out of the plane of the pyrazole ring by 75.1 (1) and 39.5 (1). Related literature For the pharmacological and medicinal properties of pyrazole derivatives, see: Baraldi et al (1998); Bruno et al (1990); Cottineau et al (2002); Londershausen (1996); Chen & Li (1998); Mishra et al (1998); Smith et al (2001). For bond-length data, see: Jin et al (2004)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Acta Crystallographica Section E Structure Reports Online
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.